Ryvu Therapeutics S.A. (WSE:RVU)
Poland · Delayed Price · Currency is PLN 27.80
+0.30 (1.09%)
Jan 7, 2026, 5:01 PM CET
Ryvu Therapeutics Market Cap
Ryvu Therapeutics has a market cap or net worth of 635.8 million as of January 7, 2026. Its market cap has decreased by -43.71% in one year.
Market Cap
635.80M
Enterprise Value
594.44M
Revenue
90.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.80
Market Cap Chart
Since July 14, 2011, Ryvu Therapeutics's market cap has increased from 56.50M to 635.80M, an increase of 1,025.25%. That is a compound annual growth rate of 18.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 635.80M | 1.48% |
| Dec 30, 2025 | 626.56M | -29.61% |
| Dec 30, 2024 | 890.13M | -33.04% |
| Dec 29, 2023 | 1.33B | 16.75% |
| Dec 30, 2022 | 1.14B | 1.70% |
| Dec 30, 2021 | 1.12B | 23.98% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.84B |
| NEUCA | 3.70B |
| Synektik Spólka Akcyjna | 2.46B |
| Voxel | 1.28B |
| Celon Pharma | 1.10B |
| Selvita | 811.31M |
| Centrum Medyczne ENEL-MED | 509.05M |
| Scope Fluidics | 442.92M |